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This study provides the initial biochemical, microscopic, and genetic characterization of the product of the vaccinia virus
E10R gene, which belongs to the ERV1/ALR family of eukaryotic proteins, is conserved in all poxviruses and has homologs
in other cytoplasmic DNA viruses. DNA encoding a short epitope tag was appended to the C-terminus of the 95-amino-acid
open-reading frame without affecting virus reproduction. The E10R protein was synthesized after DNA replication and was
associated with purified intracellular mature virions (IMV), from which it could be extracted with a nonionic detergent.
Antibody to the tag decorated the surface of IMV, consistent with the anchorage of the E10R protein to the membrane via
its hydrophobic N-terminus. Immunoelectron microscopy revealed that the E10R protein was associated with crescent
membranes, immature virions, IMV, and extracellular particles. To investigate the role of E10R in the virus life cycle, we
constructed an inducer-dependent null mutant. In the absence of inducer, the formation of infectious virus was severely
inhibited and electron microscopy revealed an assembly block with accumulation of crescent membranes and immature
virions. Cysteines 43 and 46, comprising a putative redox motif common to all poxvirus E10R homologs, were essential for
complementation of the mutant virus by transfected E10R DNA. © 2000 Academic Press
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The Poxviridae comprise a large family of complex
DNA viruses that replicate in the cytoplasm of a variety of
animals from insects to mammals (Moss, 1996). Poxvirus
genes fall into two major categories: (i) “essential” genes
that are common to all poxviruses and encode proteins
involved in replication, transcription, and virion morpho-
genesis; and (ii) “nonessential” genes that are involved in
virus–host interactions but are not required for replica-
tion in at least some cell lines. The determination of the
functions of many genes in the first category has pro-
duced a general outline of the poxvirus reproductive
cycle. Nevertheless, several fundamental aspects of pox-
virus biology remain poorly understood. These include
the mechanisms involved in virus entry into cells, DNA
replication, and the initial stages of virion morphogene-
sis. The availability of complete genome sequences of
several distantly related poxvirus species allows the
identification of viral genes that are highly conserved and
therefore expected to be essential for virus replication.
Of these genes, about a dozen, including E10R, remain
uncharacterized. Sequence analysis showed that E10R
belongs to the ERV1/ALR family of eukaryotic proteins,
has homologs in other cytoplasmic DNA viruses, and
contains a C-X-X-C sequence with potential redox activ-
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244ity (Senkevich et al., 1997). Here we show that the E10R
rotein is expressed late in infection and is associated
ith the surface of intracellular mature virions (IMV).
sing an improved procedure, we constructed an induc-
ble, conditional lethal E10R mutant that exhibits a block
n morphogenesis under nonpermissive conditions. The
wo cysteines comprising the C-X-X-C motif were re-
uired for complementation of the mutant by transfected
10R DNA.
RESULTS
Temporal expression of the E10R protein. The E10R
ene was predicted to encode a 95-amino-acid protein
ith a N-terminal hydrophobic sequence preceded by a
ypical vaccinia virus late promoter with a TAAATG tran-
cription initiation element overlapping the translation
nitiation codon (Senkevich et al., 1997). To detect the
10R protein in infected cells and virions, we constructed
recombinant vaccinia virus called vE10R-HA in which
n influenza virus nonapeptide HA-tag coding sequence
as linked to the C-terminus of the ORF, which remained
nder the control of the native E10R promoter (Fig. 1A).
o enable the isolation of recombinant viruses by color
creening, a copy of the b-glucuronidase (GUS) gene
under the control of a vaccinia virus early/late promoter
was simultaneously inserted downstream of the HA-
tagged E10R gene (Fig.1A). vE10R-HA was plaque puri-
fied and the genotype was confirmed by polymerase
chain reaction (PCR). Neither virus growth or plaque size
ET
g
a
t
E
v
u
P
v
245VACCINIA VIRUS E10R MEMBRANE PROTEINof vE10R-HA was impaired (not shown). Together with
data presented below that the E10R gene is essential for
virus replication, we concluded that the addition of a HA
tag and the expression of the GUS gene had no delete-
rious effect on the expression or function of the E10R
protein.
Synthesis of the epitope-tagged E10R protein was
demonstrated by SDS-PAGE and Western blotting using
an influenza virus HA epitope-specific antibody. A protein
with the predicted mass of 12 kDa was detected by 5.5 h
after infection and increased in amount thereafter, as
expected for a late protein (Fig. 2A). Also as expected for
a late protein, synthesis of the E10R protein was not
detected when viral DNA replication was inhibited with
AraC (Fig. 2A). The electrophoretic mobility of the tagged
protein made in vivo was identical to the mobility of
10R-HA synthesized in vitro using a 16% polyacryl-
amide–Tricine gel for optimal resolution (data not
shown), suggesting that the N-terminal hydrophobic se-
quence was retained.
E10R is associated with the surface of IMV. Vaccinia
virus late proteins are frequently associated with virus
particles. To determine whether this was true for the
E10R protein, we purified vE10-HA virions using a stan-
dard procedure that included sedimentation through a
sucrose cushion and two consecutive sucrose gradients.
The 12-kDa E10R protein was detected by Western blot-
ting with the anti-HA antibody and the majority was
released with the nonionic detergent Nonidet-P40 (Fig.
FIG. 1. Construction of recombinant vaccinia viruses. (A) vE10R-HA.
he site of insertion of the HA-tag and GUS reporter gene into the
enome of vaccinia virus is shown. Abbreviations: E9L, E10R, and E11L
re vaccinia virus ORFs; PE10, native E10R promoter; HA, HA-tag joined
o the C-terminus of E10R gene; PE/L, early/late synthetic promoter
driving the expression of the GUS gene. PCR1, PCR2, and PCR3 rep-
resent individual PCR products that were assembled by recombinant
PCR to form PCR4. PCR4 was used directly for homologous recombi-
nation with wild-type vaccinia virus strain WR. (B) vE10Ri. The site of
insertion of the GUS reporter gene and T7 promoter (PT7) and modified
. coli lac operator (lacO) regulating the E10R gene into the genome of
accinia virus are shown. PCR19, PCR29, and PCR39 represent individ-
al PCR products that were assembled by recombinant PCR to form
CR49. PCR49 was used directly for homologous recombination with
T7lacOI virus.2B). The addition of DTT with the detergent (Fig. 2B) or
after detergent treatment did not significantly improvethe extraction, suggesting that the E10R protein is lo-
cated near the virion surface.
The purified virions were examined by electron mi-
croscopy and found to be largely free of contaminating
membranes. The surface of intact vE10-HA virions was
extensively decorated with protein A gold following incu-
bation with polyclonal anti-HA antibody (Fig. 3A), in con-
trast to the near absence of surface staining of control
wild-type virions (Fig. 3B). Taken together, the biochem-
ical and microscopic analyses suggested that the E10R
protein is virion-associated. A likely topology is that the
N-terminal hydrophobic segment is anchored in the
membrane with the C-terminus accessible to antibody.
Localization of the E10R protein in immature and ma-
ture virus structures. The association of the E10R protein
with IMV could occur at early or late stages of virus
morphogenesis. To determine which viral structures con-
tained the E10R protein, ultrathin cryosections of cells
infected with vE10-HA were stained with a monoclonal
antibody to the HA tag followed by anti-mouse IgG anti-
body and protein A gold. Gold grains were associated
with crescent membranes (Fig. 3C, insert), spherical im-
mature virions (Fig. 3C), brick-shaped IMV (Fig. 3E), and
extracellular virions (not shown). Some grains were also
associated with unidentifiable membranous structures in
the factory regions. The similar densities of the gold
grains in immature and mature virions suggested that
the association of the E10R protein with viral membranes
occurred at an early stage of morphogenesis. The spec-
ificity of protein A–gold labeling was demonstrated by
FIG. 2. SDS-PAGE of the E10R protein from infected cell extracts and
purified virions. (A) Time course of E10R-HA accumulation. BS-C-1 cells
were incubated with 5 PFU/cell of vE10R-HA for 1 h; unadsorbed virus
was removed by washing the cell monolayers three times with medium,
and incubation was continued for indicated periods of time. Additional
cells were incubated with AraC (40 mg/ml) for 2 h prior to the addition
of the virus and AraC was present continuously thereafter. Aliquots of
the total cell extracts were dissociated with SDS and DTT and analyzed
in a 10–20% polyacrylamide Tris–glycine gel. The E10R-HA protein was
detected by Western blotting using an anti-HA antibody and chemilu-
minescence assay. The mass of the protein indicated by the arrow was
determined by coelectrophoresis of protein standards. (B) Extraction of
the E10R protein from purified virions. Sucrose gradient purified virions
were resuspended in PBS–1% NP-40, with or without 50 mM DTT,
sonicated, and incubated for 30 min at 37°C. Insoluble material was
collected by centrifugation and similar proportions of the pellet (P) and
supernatant (S) were analyzed by SDS-PAGE as described in panel A.
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246 SENKEVICH, WEISBERG, AND MOSSthe absence of significant background in cells infected
with wild-type vaccinia virus (Figs. 3D and 3F).
Construction of an E10R inducible mutant. Because of
the high conservation of the E10R gene in other poxvi-
ruses, we suspected that it would be essential for virus
replication in cell culture. Therefore, to determine its role
in the vaccinia virus life cycle, we constructed an induc-
ible mutant using a modification of a previously de-
scribed high-stringency system of regulated gene ex-
pression (Ward et al., 1995). The recombinant vaccinia
irus produced in the inducible system contains three
ain components: (i) a constitutively expressed E. coli
FIG. 3. Immunoelectron microscopy of purified virions and infected c
irus (B), were adsorbed to grids and stained with polyclonal anti-HA
arker is shown. Ultrathin cryosections of cells infected with vE10R-HA
ntibody, anti-mouse IgG antibody, and10-nm gold particles conjugated
re shown with a 500-nm marker. The insert in panel C shows a cresac repressor gene (lacI); (ii) a bacteriophage T7 RNA
olymerase gene regulated by a late vaccinia virus pro-
n
(moter and a modified E. coli lac operator (lacO); and (iii)
n inducible gene regulated by the T7 promoter, a mod-
fied lacO, and an encephalomyocarditis virus (EMCV)
eader sequence (Ward et al., 1995). In this system, the
ac repressor inhibits two consecutive steps, namely
ranscription of the T7 RNA polymerase gene and the
ene of interest, thereby providing the basis for high
tringency. Controlled expression of the inducible gene
s achieved by addition of the desired concentration of
sopropyl-b-D-thiogalactoside (IPTG). Although this sys-
em was designed for high-level expression of foreign
enes, it has been used to successfully construct a
ions. Purified virion preparations of vE10R-HA (A), or wild-type vaccinia
a followed by protein A conjugated to 10 nm colloidal gold. A 250-nm
r wild-type vaccinia virus (D, F) were incubated with monoclonal HA11
tein A. Typical fields containing predominantly IV (C, D) and IMV (E, F)
higher magnification with a 125-nm marker.ell sect
antiser
(C, E) oumber of vaccinia virus inducer-dependent mutants
Cassetti et al., 1998; Wolffe et al., 1996). Nevertheless,
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247VACCINIA VIRUS E10R MEMBRANE PROTEINthe system has some shortcomings: (i) the construction
is lengthy, involving two virus recombination and cloning
steps consisting of insertion of the inducible copy of the
vaccinia virus gene and deletion of the original one; (ii)
the insertion site is the nonessential A56R gene, which
encodes the viral hemagglutinin, and mutants have a
syncytial phenotype; (iii) the presence of the EMCV
leader sequence, which provides enhanced cap-inde-
pendent translation, could potentially result in inducer-
independent translation of RNAs that start far upstream
of the lac O. We therefore designed a modified system
hat would address each of these points (Fig. 1B). The
10R gene was kept in its original position in the viral
enome with the T7 promoter and lacO placed upstream
of it, thereby avoiding a two-step procedure as well as
the disruption of the vaccinia virus hemagglutinin gene.
The EMCV leader was omitted since very high expres-
sion was unnecessary and the triple transcription termi-
nator was also eliminated because it was found to be
nonessential. In the new system, a cassette containing
the GUS gene for color screening of recombinant viruses
followed by the T7 promoter and lacO was inserted
between the E10R promoter and the E10R ORF by ho-
mologous recombination using flanking sequences of
;500 bp each (Fig. 1B). This cassette was assembled
from three PCR products by recombinant PCR, and the
linear PCR product was used directly for homologous
recombination with vT7lacOI, a virus already containing
the T7 RNA polymerase and lac repressor. An IPTG-
dependent E10R mutant (vE10Ri) was isolated after three
cycles of cloning in the presence of 100 mM IPTG.
vE10Ri did not form plaques in the absence of IPTG
nd plaque size showed a positive correlation with IPTG
oncentration, reaching almost the size of the parental
T7lacOI virus at greater than 50 mM (not shown). Cor-
esponding results were obtained by determining virus
ields under one-step growth conditions. The vE10Ri
ield at 24 h postinfection was more than 100-fold higher
n the presence of IPTG than in its absence (Fig. 4). The
irus yield increased most dramatically between 5 and
0 mM IPTG, with the optimal concentration between 50
nd 100 mM (Fig. 4). A further increase in the IPTG
concentration up to 1 mM had no effect on the virus titer.
In contrast, the yield of the parental vT7lacOI virus was
independent of IPTG (Fig. 4). The slightly lower yield of
vE10Ri at optimal IPTG compared to vT7lacOI or wild-
type vaccinia virus was probably not due to low expres-
sion of E10R, since the strength of the T7 system has
been documented with other proteins. Regardless, this
was not a significant problem as high titer stocks of
mutant viruses were obtained.
Complementation of the E10R inducible null mutants
using plasmid-expressed E10R. To confirm that the de-
fect in the recombinant virus carrying the inducible copy
of E10R was caused solely by repression of this gene, we
sought to demonstrate complementation by trans ex-pression of the E10R protein. To this end, cells infected
with vE10Ri in the absence of IPTG were transfected with
a plasmid containing the HA-tagged E10R gene under
the control of the vaccinia virus strong P11 late promoter.
The plasmid-expressed E10R rescued the mutant, with
the virus yield increasing more than tenfold (Fig. 5A).
Under these complementation conditions, the yield of
virus was lower than in the presence of inducer (Fig. 5A),
probably reflecting the inefficiency of transfection.
Requirement for the C-X-X-C motif. The E10R protein
contains a C-X-X-C signature (C43 and C46) that is con-
served in all poxvirus homologs, suggesting that it may
function as a redox active site (Senkevich et al., 1997).
E10R also contains a third cysteine (C30), which is con-
served only among the orthologous protein of closely
related orthopoxviruses. We constructed mutant plas-
mids in which the cysteines of E10R were individually
replaced with serines and assessed their ability to com-
plement the inducible null-mutant vE10Ri in the absence
of IPTG. We found that elimination of either cysteine of
the C-X-X-C motif completely abolished the ability of the
respective plasmid to rescue virus replication, whereas
replacement of the nonconserved C30 had no effect (Fig.
5A). The mutant proteins were expressed at approxi-
mately the same level compared to the wild-type control
(Fig. 5B), indicating that the effect did not result from poor
expression or instability of the mutated proteins.
The role of the E10R protein in the virus life cycle. The
above experiments indicated that E10R protein is an IMV
component that is required for virus growth in cell cul-
ture. Since the E10R gene is itself expressed late in
FIG. 4. Dependence of vE10Ri yield on IPTG concentration. BS-C-1
cells were infected with 5 PFU/cell of vE10Ri or vT7lacOI; after 1 h the
unadsorbed inoculum was removed by three cycles of washing; IPTG
was then added at indicated concentrations and the incubation was
continued for 24 h. The virus yields were determined by plaque assay
in the presence of 100 mM IPTG.infection, it seemed unlikely that it would be needed for
the synthesis of viral DNA or late proteins. The latter was
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248 SENKEVICH, WEISBERG, AND MOSSinvestigated by [35S]methionine labeling of cells at 12 h
fter infection with vE10Ri in the presence or absence of
PTG. The typical pattern of late protein synthesis was
ualitatively and quantitatively similar regardless of the
resence or absence of the inducer (data not shown). A
hase, however, revealed decreased maturational pro-
essing of major core proteins under nonpermissive con-
itions as demonstrated for other inducible mutants that
re blocked in virus assembly (Zhang and Moss, 1991,
992). To determine the effect of E10R repression on
orphogenesis, sections of infected cells were exam-
ned by transmission electron microscopy. Cells infected
ith vE10Ri in the presence of IPTG showed the ex-
ected range of virus structures (Fig. 6) that were indis-
inguishable from those produced by the parental
T7lacOI or wild-type virus. Such infected cells contained
arge clusters of mature virions and extracellular parti-
les as well as some immature forms, mostly IV and
rescent membranes. Without IPTG, however, mature
irions were rare and typical fields of vE10Ri infected
ells contained crescents adjacent to large masses of
ranular material and numerous immature virions
Fig. 6).
DISCUSSION
FIG. 5. Complementation of vE10Ri with plasmids expressing wild-
type or mutated E10R-HA. (A) BS-C-1 cells were infected with 5 PFU/
cell of vE10Ri in the absence or presence of 100 mM IPTG. After 1.5 h,
he cells were transfected with plasmids containing mutated (cysteine
utated to serine indicated) or wild-type (WT) E10R-HA genes under
ontrol of a strong late promoter or mock-transfected (M). Cells were
ollected after 24 h and virus yields were determined in the presence
f 100 mM IPTG. (B) Lysates from cells infected with vE10Ri in the
absence of IPTG and transfected with plasmids containing wild-type or
mutated E10R-HA were analyzed by Western blotting using polyclonal
antibody to the HA tag. The arrow points to the 12-kDa protein.The present study provides the initial biochemical,
icroscopic, and genetic characterization of the product
s
cf the vaccinia virus E10R gene. The DNA sequence
redicted a 95-amino-acid polypeptide with a hydropho-
ic N-terminus preceded by a late-stage promoter. We
emonstrated that the synthesis of the E10R protein
ccurred late after infection and was dependent on DNA
eplication. The protein had the expected SDS-PAGE
obility of a 12-kDa polypeptide, consistent with the
bsence of proteolytic processing or glycosylation. The
10R protein was associated with purified virions and
as extracted with a nonionic detergent in the absence
f DTT, a characteristic of other IMV membrane-associ-
ted proteins. The ability to decorate the surface of intact
irions with antibody to an epitope tag appended to the
-terminus of the E10R protein suggested that anchor-
ge occurred via the N-terminal hydrophobic domain,
lthough the topology needs to be confirmed by other
ethods. Immunoelectron microscopy of infected cell
ections revealed that the association of the E10R pro-
ein with the IMV membrane occurs at an early stage of
orphogenesis, prior to the formation of spherical im-
ature virions. Whether this occurs via the classical
RP/Sec61p pathway (Rapoport, 1992) or by other post-
ranslational mechanisms is unknown at this time. Re-
ently, evidence for the posttranslational insertion of an-
ther IMV membrane protein by a C-terminal hydropho-
ic region was reported (Da Fonseca et al., 2000).
Genetic studies were undertaken to provide informa-
ion regarding the role of the E10R protein in virus rep-
ication. For this purpose, an IPTG-inducible E10R mutant
as made using an improved procedure with general
pplicability. In the absence of IPTG, (i) plaque formation
as inhibited; (ii) there was a 100-fold reduction in virus
ield under one step growth conditions; and (iii) virus
orphogenesis was interrupted, resulting in the accu-
ulation of large masses of granular material sur-
ounded by crescent membranes and immature virions.
his assembly block was consistent with immunoelec-
ron microscopy data showing the association of the
10R protein with immature as well as mature virus
articles. Evidently, E10R function is directly or indirectly
equired for morphogenesis.
Our interest in the E10R gene stemmed from the pres-
nce of homologs in all sequenced poxviruses and its
imilarity to members of the diverse ERV1/ALR family of
ukaryotic proteins, most of which have no known func-
ion (Polimeno et al., 1999). The family takes its name
rom the essential yeast protein ERV1, which is required
or mitochondrial biogenesis and was named Essential
or Respiration and Vegetative growth (Lisowsky, 1994)
nd the mammalian hematopoetin (alternatively named
LR for its role as an Augmenter of Liver Regeneration;
agiya et al., 1994). African swine fever virus (ASFV) is an
cosahedral virus that is genetically distinct from poxvi-
uses but shares certain features, including the genome
tructure and cytoplasmic site of replication. ASFV en-
odes a protein that belongs to the ERV1/ALR family and
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249VACCINIA VIRUS E10R MEMBRANE PROTEINwhich is similar in size to E10R but is not associated with
virions (Lewis et al., 2000). Nevertheless, the ASFV ERV1/
LR homolog was shown to have a role in virion mor-
hogenesis.
The presence of a C-X-X-C sequence, common to all of
he poxvirus E10R homologs, is also part of the ;100
amino acids ERV1/ALR domain. The complementation
studies described here showed that the cysteines com-
prising the C-X-X-C motif of E10R were crucial for vac-
cinia virus replication but that the third cysteine of E10R,
which is not conserved in other ERV1/ALR family mem-
bers, was not required. Repression of the vaccinia virus
G4L glutaredoxin, which also has a C-X-X-C motif, was
recently shown to result in a block in morphogenesis at
a stage similar to that described for E10R (White et al.,
2000). Furthermore, repression of the E10R gene or mu-
tation of the E10R redox cysteines prevented the forma-
FIG. 6. Electron microscopy of vE10Ri-infected cells in the presence
bsence of 100 mM IPTG, fixed, embedded in EPON, and ultrathin sec
he presence or absence of IPTG are shown. Abbreviations: C, cresc
nveloped virions; CEV, cell-associated enveloped virions. Magnificatition of disulfide bonds in the G4L glutaredoxin and other
viral proteins, indicating that the E10R and G4L proteinsare components of a viral thiol oxidation pathway (Sen-
kevich et al., 2000).
MATERIALS AND METHODS
Cells and viruses
BS-C-1 cells (ATTC CCL6) were used for all experi-
ments and were grown in Eagle’s minimum essential
medium (EMEM; Quality Biologicals) supplemented with
10% fetal bovine serum. The medium for infected cells
was supplemented with 2.5% serum. All recombinant
vaccinia viruses were derived from the WR strain (ATTC
Vr119). VT7lacOI (Alexander et al., 1992), the parental
virus for generating the isopropyl-b-D-thiogalactoside-
inducible mutant, contains an inducible copy of bacterio-
phage T7 RNA polymerase gene and an E. coli lac
repressor gene inserted into the nonessential thymidine
ence of IPTG. BS-C-1 cells were infected for 24 h in the presence or
repared. Typical low and high power fields of vE10Ri-infected cells in
, immature virions; IMV, intracellular mature virions; IEV, intracellular
dicated by bars.or abs
tions pkinase locus. vE10-HA is a recombinant vaccinia virus
containing the E10R gene with a C-terminal HA-tag; vE10i
E250 SENKEVICH, WEISBERG, AND MOSSis vaccinia virus recombinant with an inducible E10R
gene. Standard procedures used for propagation, titra-
tion, and purification of vaccinia virus were described
previously (Earl et al., 1998).
Generation of vE10-HA
Recombinant PCR (Expand High Fidelity PCR System,
Roche Biochemicals) was used to construct a DNA seg-
ment containing (i) the E10R gene with an HA epitope tag
sequence encoding the nonapeptide YPYDVPDYA de-
rived from the influenza virus hemagglutinin; (ii) followed
by a vaccinia virus early/late synthetic promoter
(Chakrabarti et al., 1997) and the coding sequence of the
. coli b-glucuronidase gene; and (iii) flanking se-
quences to permit homologous recombination into the
vaccinia virus genome (Fig. 1A). The final sequence
(TATCCATATGATGTTCCAGACTATGCTTCTTAAATTGAA-
ATTTTATTTTTTTTTTTTGGAATATAAATG) contains
codons for the HA epitope (bold italics) plus an addi-
tional serine codon (TCT) followed by a stop codon (TAA)
that was directly fused and partly overlapped with the
sequence of a modified (the first two A’s replaced with
T’s) vaccinia virus early/late synthetic strong promoter
(underlined). For efficient translation (Kozak, 1989), the
second codon TTA of the GUS gene was replaced by
GTA that resulted in a replacement of a leucine with
valine. The first PCR product (PCR1, Fig. 1A) used to
construct vE10R-HA contained the 39-terminal part (start-
ing from the nucleotide 10) of the sequence shown above
fused to the rest of the GUS gene sequence and ending
with the stop codon of the GUS gene followed by AT
(GATGTTCCAGACTATGCTTCTTAAATTGAAATTTTATTT-
TTTTTTTTTGGAATATAAATGGTACGT . . . GCAGGGAG-
GCAAACAATGAAT), where the HA sequence is bold ital-
icized, the early/late promoter is in regular italics, and
the rest of the sequence including . . . represents the
GUS gene. This PCR construction was used as the first
step in attaching a C-terminal HA tag to the E10R gene
as well as to produce other HA-tagged vaccinia virus
genes (T. G. Senkevich, unpublished). The second PCR
product (PCR2, Fig. 1A) contained the left flank of the
E10R gene together with the coding sequence of the
E10R gene fused to the HA-tag-coding sequence. The
HA-tag-coding sequence provided an overlap with the
PCR1 DNA. The third PCR product (PCR3, Fig. 1A) con-
tained the right flank of the E10R gene with the 39-
terminal sequence of the GUS gene to provide an over-
lap with the PCR1. The insertion of the GUS gene after
the E10R gene did not disrupt the downstream E11L ORF
because the only stop codons of E10R and E11L overlap
the last triplets of each other’s coding regions. The se-
quences upstream and downstream of the E10R gene
were included to allow the subsequent homologous re-
combination into the viral genome. The three DNA frag-
ments (PCR1, 2, and 3) were combined using recombi-nant PCR, and the final PCR product (PCR4) was used
directly for homologous recombination with vaccinia vi-
rus strain WR. The possibility of producing recombinant
vaccinia virus using linear DNA fragments assembled by
recombinant PCR was demonstrated earlier (Turner and
Moyer, 1992). Cells were infected with 1 PFU/cell of
vaccinia virus and transfected with the PCR4 DNA in
lipofectAMINE according to the manufacturer’s protocol
(Life Technologies). At 24 h after infection, the virus was
harvested and used in different dilutions to infect new
cell monolayers. To isolate recombinant viruses, the in-
fected cells were overlaid with agar, incubated for 48 h,
and overlaid with a second layer of agar containing 200
mg/ml of X-gluc (Clontech Laboratories, Palo Alto, CA).
After an additional 24–48 h, blue plaques containing
recombinant viruses expressing the GUS gene were
picked, and recombinant virus was purified by three
cycles of cloning. The efficiency of homologous recom-
bination was high enough to isolate recombinants pro-
ducing blue plaques without any additional selection.
About one blue plaque was found among 200 white
plaques in the first round of screening.
Generation of vE10Ri
An oligonucleotide (CAGGGAGGCAAACAATGA-
ATCGAAATTAATACGACTCACTATAGGGAATTGTGAGCG-
CTCACAATTCCCGCCGCCACC) comprising the 39-
terminal part of the GUS gene fused with the T7 pro-
moter, modified lac operator (Ward et al., 1995), and the
consensus for the initiation of translation (Kozak, 1989)
was synthesized chemically by Bio-Synthesis, Inc.
(Lewisville, TX) and joined to the GUS gene by recombi-
nant PCR. This DNA fragment (PCR19, Fig. 1B) was used
as the first step in producing vE10Ri as well as IPTG-
inducible mutants in other vaccinia virus genes (T. G.
Senkevich, unpublished). The coding sequence of the
GUS gene was linked to the sequence upstream of the
E10R ORF containing the native E10R promoter; the sec-
ond codon of GUS was replaced to keep the same
nucleotide as E10R in the 14 position. Thus, the GUS
gene was placed under the control of the E10R promoter
(CCATTTATAGAATTTAGAAATATATTTTCATTTAAATG-
ATACGTCCTGTAGAAACCCC); the sequence preceding
the E10R ORF with A in position 14 is italicized. The
complete construction containing the left and right flanks
of E10R gene was assembled by recombinant PCR (Fig.
1B) and used directly for homologous recombination with
vT7lacOI. The recombinant virus vE10Ri was isolated
using exactly the same procedure as described above
for the vE10R-HA; the only difference was the presence
of 100 mM of IPTG in the agar overlay to allow the
reproduction of vE10Ri.
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The E10R gene containing the C-terminal HA tag was
placed under control of the strong late vaccinia virus P11
promoter for expression purposes. The sequence of vac-
cinia P11 promoter (GAATTTCATTTTGTTTTTTTCTATGC-
TATAAATG) was included at the 59-end of the forward
PCR primer upstream of the ATG start codon (under-
lined); the HA-tag sequence (TATCCATATGATGTTCCA-
GACTATGCT) with additional TCT (serine) and TAG (stop)
codons was included (in the reverse orientation) at the
59-end of the reverse PCR primer. The PCR product was
purified using the Wizard PCR Preps Kit (Promega) and
cloned in the pGEM-T vector (Promega). Cysteine to
serine mutations of the E10R gene were constructed
using recombinant PCR with internal primers containing
the corresponding one-nucleotide substitutions and the
same external primers as above. All constructs were
verified by sequencing. To express the E10R-HA under
the control of a T7 promoter, a forward PCR primer
starting with the ATG codon of the E10R gene at the
59-end and the same reverse primer as above was used,
and the PCR product was cloned in pTargeT expression
vector (Promega).
Transfection of vaccinia virus-infected cells with
recombinant plasmids for transient expression
BS-C-1 cells in a 24-well plate were infected with 10
plaque-forming units (PFU) of vE10Ri and, after 1.5 h,
transfected with plasmid DNA mixed with lipofectAMINE
according to the manufacturer’s protocol (Life Technolo-
gies). After 2 h, IPTG was added to the transfection
mixture. Cells were collected 18–24 h after infection.
Cell-free transcription/translation
The reticulocyte lysate-based TNT Quick Coupled
Transcription/Translation System (Promega) was used
as directed by the manufacturer. E10R-HA DNA cloned in
pTargeT expression vector as described above was
used as a template. An aliquot of the reaction was
resolved in SDS-PAGE and detected by Western blotting
with anti-HA antibody.
Western blot analysis
Infected or infected and transfected BS-C-1 cells were
collected by centrifugation, washed with phosphate buff-
ered saline (PBS), and disrupted in Laemmli gel loading
buffer by sonication and boiling and applied to a SDS-
polyacrylamide gel. A 16% polyacrylamide tricine gel
(NOVEX) was used to separate small proteins, and 10–
20% polylacrylamide gradient Tris–glycine gel (NOVEX)
was used for all other protein separations. Proteins were
transferred to nitrocellulose, incubated with the corre-
sponding antibodies directly conjugated to peroxidase or
followed by peroxidase-conjugated secondary antibod- Mies, and detected with chemiluminescent detection kits
(Pierce, Rockford, IL). PBS with 0.1% Tween and 5% non-
fat dry milk was used for membrane blotting and incu-
bation with antibodies.
Antibodies
Peroxidase-conjugated anti-HA rat monoclonal anti-
body (Clone 3F10, Roche) was used to detect HA-tagged
proteins in Western blotting. Mouse monoclonal
Mab.HA.11 and polyclonal rabbit HA.11 (BabCo/Covance,
Berkeley, CA) were used to detect the HA epitope by
electron microscopy in cryosections and on the surface
of purified virions, respectively.
Electron microscopy
Electron microscopy was performed as described pre-
viously (Da Fonseca et al., 2000; Wolffe et al., 1996).
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